Related Experiment Video
Updated: Jan 22, 2026

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma
Published on: April 16, 2019
Treating Immunoglobulin A Vasculitis in an Elderly Patient Using Steroids: A Clinical Study
Kohei Ono1,2, Yoshihiro Fukoe3, Yugen Lee3
1Department of Gastroenterological Surgery, Shiroyama Hospital, Gunma, Japan cohey.o@med.showa-u.ac.jp.
This case report highlights immunoglobulin A vasculitis (IgAV) in an elderly patient, presenting with palpable purpura and abdominal pain. Early consideration of IgAV is crucial for elderly patients with these symptoms.
Area of Science:
- Rheumatology
- Nephrology
- Gastroenterology
Background:
- Immunoglobulin A vasculitis (IgAV) is a common childhood vasculitis.
- IgAV onset in elderly patients is rare, with limited reported cases.
Observation:
- A 61-year-old male presented with palpable purpura and abdominal pain.
- CT scans showed thickened intestinal walls and ascites.
- Elevated serum IgA and urinary protein levels were noted.
Findings:
- Histopathology confirmed vasculitis in the palpable purpura.
- The patient was diagnosed with immunoglobulin A vasculitis (IgAV).
- Steroid therapy led to symptom resolution.
Implications:
- This case underscores the importance of considering IgAV in elderly patients presenting with purpura and abdominal pain.
- Early diagnosis and treatment of IgAV in older adults can lead to favorable outcomes.
- Further research is needed to understand IgAV presentation and management in the elderly population.
Related Concept Videos
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Bioavailability Study Design: Healthy Subjects Versus Patients
